SI-BONE (SIBN) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does SI-BONE (SIBN) do?
SI-BONE Inc (SIBN) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Manufactures titanium implant systems used by orthopedic surgeons to treat lower back pain. Sells these triangular implants and related surgical instruments directly to hospitals. Develops and sells specialized implant systems specifically designed for fusion of the sacroiliac joint. It is worth $1.07B on the market and sold $220.46M over the last year.
- Market cap
- $1.07B
- P/E ratio
- None (reported a loss)
- Annual sales
- $220.46M
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 18, 2026
Brands and businesses behind SIBN
- iFuse: Triangular titanium implants that generate revenue when purchased by hospitals for sacroiliac joint fusion procedures.
- iFuse Bedrock: Specialized sacropelvic screws that generate sales when used by surgeons during complex adult spinal deformity operations.
- iFuse TORQ: Threaded titanium implants that generate revenue from pelvic fracture repairs and joint stabilization procedures.
SIBN’s flags, in plain English
Each flag is a number from SI-BONE’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 18, 2026.
Stupid Cash
Can pay this year's bills 7.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 79.4% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Low debt
Low debt, only 23% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Burning Cash
Losing money, profit margin of -6.2%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
1 more green flag and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about SIBN
How big is SI-BONE?
SI-BONE’s market cap is $1.07B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $220.46M: what customers paid the company over the last year, before any costs.
What is SIBN’s P/E ratio?
SIBN has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with SIBN?
The company generates recurring net losses and relies heavily on ongoing revenue growth to reach operating profitability. That is one risk on SI-BONE’s card. Its first risk flag is Burning Cash, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From SI-BONE’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. SIBN’s filings on SEC.gov. The Margin Monkey is research, not advice.
